Cohort Study: Modelling Toxicity Processing in Patients Treated by Immunotherapy (MOTIVATE).
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Solid Tumor
Related studies linked through entity extraction aliases.
Study to Evaluate the Safety and Tolerability of RXC004 in Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Assess the Safety and Activity of Combined MG005 and Sorafenib (NEXAVAR®) Treatment With Solid Tumor
- Status
- COMPLETED
- Phase
- PHASE1
Study of Boserolimab (MK-5890) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Adults With Advanced Solid Tumors (MK-5890-001)
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1 Study Evaluating VT1021 in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Pharmacokinetic and Safety Study of Niraparib With Normal or Moderate Hepatic Impairment Patients
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY3381916 Alone or in Combination With LY3300054 in Participants With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Dabrafenib and/or Trametinib Rollover Study
- Status
- RECRUITING
- Phase
- PHASE4
A Study of HS-196, an HSP90 Inhibitor-linked NIR Probe for Solid Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Pharmacokinetics and Tolerancebility Studies of Gentuximab Injection in the Treatment ofPatients With Late Recurrence of Metastatic Solid Tumors in China
- Status
- UNKNOWN
- Phase
- PHASE1
Sym021 Monotherapy, in Combination With Sym022 or Sym023, and in Combination With Both Sym022 and Sym023 in Patients With Advanced Solid Tumor Malignancies or Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
Study of Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042
- Status
- COMPLETED
- Phase
- PHASE1
A Study of PLX2853 in Advanced Malignancies.
- Status
- COMPLETED
- Phase
- PHASE1
LZM009 to Treat Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Comparison of Three Tissue Acquiring Techniques During EUS Guided Biopsies of Solid Tumors.
- Status
- TERMINATED
- Phase
- NA
Association of Genetic Polymorphisms With Capecitabine-based Chemotherapy Toxicities in Chinese Solid Tumor Patients
- Status
- UNKNOWN
- Phase
- N/A
Study of MK-2118 Administered as Intratumoral Injection as Monotherapy and in Combination With Pembrolizumab (MK-3475) or by Subcutaneous Injection in Combination With Pembrolizumab in the Treatment of Adults With Advanced/Metastatic Solid Tumors or Lymphomas (MK-2118-001)
- Status
- TERMINATED
- Phase
- PHASE1
TCR-engineered T Cells in Solid Tumors (ACTengine IMA201-101)
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1 Study to Investigate Axatilimab Alone or in Combination With Durvalumab in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4